CN1323676C - 治疗脾胃虚弱的中药胶囊剂的制备方法及其质量控制方法 - Google Patents
治疗脾胃虚弱的中药胶囊剂的制备方法及其质量控制方法 Download PDFInfo
- Publication number
- CN1323676C CN1323676C CNB2004100691326A CN200410069132A CN1323676C CN 1323676 C CN1323676 C CN 1323676C CN B2004100691326 A CNB2004100691326 A CN B2004100691326A CN 200410069132 A CN200410069132 A CN 200410069132A CN 1323676 C CN1323676 C CN 1323676C
- Authority
- CN
- China
- Prior art keywords
- solution
- capsule
- radix pseudostellariae
- water
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 55
- 210000000952 spleen Anatomy 0.000 title claims abstract description 20
- 210000002784 stomach Anatomy 0.000 title claims abstract description 18
- 238000003908 quality control method Methods 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims description 19
- 239000003814 drug Substances 0.000 title abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 42
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims abstract description 27
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims abstract description 27
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims abstract description 27
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims abstract description 27
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims abstract description 27
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims abstract description 27
- 229940025878 hesperidin Drugs 0.000 claims abstract description 27
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000002156 mixing Methods 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 14
- 238000001035 drying Methods 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 78
- 239000000243 solution Substances 0.000 claims description 69
- 238000012360 testing method Methods 0.000 claims description 56
- 239000013558 reference substance Substances 0.000 claims description 30
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 22
- 238000004809 thin layer chromatography Methods 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 14
- 239000000741 silica gel Substances 0.000 claims description 14
- 229910002027 silica gel Inorganic materials 0.000 claims description 14
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 12
- 239000000853 adhesive Substances 0.000 claims description 12
- 230000001070 adhesive effect Effects 0.000 claims description 12
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 12
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 12
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 12
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 239000007921 spray Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 claims description 8
- 239000013078 crystal Substances 0.000 claims description 8
- INCWELKXTZCRSA-UHFFFAOYSA-N ethyl acetate;methanol;hydrate Chemical class O.OC.CCOC(C)=O INCWELKXTZCRSA-UHFFFAOYSA-N 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 230000003760 hair shine Effects 0.000 claims description 4
- 239000012567 medical material Substances 0.000 claims description 4
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 4
- 238000000079 presaturation Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 239000012047 saturated solution Substances 0.000 claims description 4
- 235000019640 taste Nutrition 0.000 claims description 4
- 239000012085 test solution Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 235000005903 Dioscorea Nutrition 0.000 claims description 3
- 241000234273 Dioscorea Species 0.000 claims description 3
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 3
- 235000004879 dioscorea Nutrition 0.000 claims description 3
- 229960000583 acetic acid Drugs 0.000 claims description 2
- 238000012850 discrimination method Methods 0.000 claims description 2
- 239000012362 glacial acetic acid Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 10
- 229940079593 drug Drugs 0.000 abstract description 5
- 239000000284 extract Substances 0.000 abstract description 3
- 239000002671 adjuvant Substances 0.000 abstract description 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 11
- 208000019790 abdominal distention Diseases 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 230000036528 appetite Effects 0.000 description 6
- 235000019789 appetite Nutrition 0.000 description 6
- 238000011084 recovery Methods 0.000 description 5
- 238000003556 assay Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 2
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
提取时间(h) | 4 | 5 | 6 |
含量(mg/粒) | 0.4295 | 0.4416 | 0.4392 |
症状 | 轻(+) | 中(++) | 重(+++) |
食欲减退(半月以上)食后腹胀大便 | 没有食欲,但保持原饭量轻微腹胀,半小时内减轻或消失,不影响生活,不需服对症药物软便或稍烂,成堆不成形,2-3次/日 | 无食欲,饭量比病前减少1/3腹胀不适在半小时至1小时内,较甚,部分影响日常生活,或需服对症药物烂便、溏便,4-5次/日,或稀便1-2次/日 | 饭量减少2/3以上3腹胀更甚,2小时以内仍不能好转,生活受影响,或服对症药物效果不佳稀便,3次/日以上 |
实验次数 | 1 | 2 | 3 | 4 | 5 | RSD% |
吸收峰面积 | 252.668 | 252.106 | 251.676 | 247.310 | 249.577 | 0.88 |
扫描间隔时间(h) | 即时 | 0.5 | 1 | 1.5 | 2 | RSD% | ||
吸收峰面积 | 对照品 | 2μl | 142.350247.318201.333 | 142.327246.727198.715 | 138.224243.273199.055 | 137.599243.699196.398 | 137.871242.576193.297 | 1.750.871.53 |
4μl | ||||||||
供试品 |
编号 | 1 | 2 | 3 | 4 | 5 | RSD% |
含量(mg/粒) | 0.397 | 0.392 | 0.404 | 0.400 | 0.396 | 1.13 |
序号 | 供试品量(g) | 橙皮苷含量(mg) | 加对照品量(mg) | 测得量(mg) | 回收率(%) | 平均回收率(%) | RSD(%) |
12345 | 0.99601.00021.01261.00151.0074 | 0.83060.83410.84440.83520.8401 | 0.6070.6070.6070.6070.607 | 1.38641.39221.45091.41621.4220 | 96.4396.6199.9698.2098.26 | 97.89 | 1.47 |
批号 | 橙皮苷含量(mg/粒) | ||
1 | 2 | 平均 | |
020701020702020703平均 | 0.4120.4170.413 | 0.4010.4180.412 | 0.410.420.410.41 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100691326A CN1323676C (zh) | 2004-07-06 | 2004-07-06 | 治疗脾胃虚弱的中药胶囊剂的制备方法及其质量控制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100691326A CN1323676C (zh) | 2004-07-06 | 2004-07-06 | 治疗脾胃虚弱的中药胶囊剂的制备方法及其质量控制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1718219A CN1718219A (zh) | 2006-01-11 |
CN1323676C true CN1323676C (zh) | 2007-07-04 |
Family
ID=35930248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100691326A Expired - Fee Related CN1323676C (zh) | 2004-07-06 | 2004-07-06 | 治疗脾胃虚弱的中药胶囊剂的制备方法及其质量控制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1323676C (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102138608A (zh) * | 2010-11-16 | 2011-08-03 | 苏州市天灵中药饮片有限公司 | 健胃消食茶 |
CN103142678A (zh) * | 2012-10-30 | 2013-06-12 | 贵阳医学院 | 太子参总苷的制备方法及其在制备预防和治疗心肌缺氧、缺血药物中的用途 |
CN105169120A (zh) * | 2015-10-27 | 2015-12-23 | 贵州苗生药业有限公司 | 一种治疗肠胃疾病的中药制剂 |
CN113599459A (zh) * | 2021-09-18 | 2021-11-05 | 冯学品 | 一种胃药及其制备方法 |
-
2004
- 2004-07-06 CN CNB2004100691326A patent/CN1323676C/zh not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
健胃消食片 部颁标准(中药成方制剂第二册) 1990 * |
健胃消食片 部颁标准(中药成方制剂第二册) 1990;健胃消食片质量标准研究 潘翠华,医学理论与实践,第16卷第12期 2003 * |
健胃消食片质量标准研究 潘翠华,医学理论与实践,第16卷第12期 2003 * |
Also Published As
Publication number | Publication date |
---|---|
CN1718219A (zh) | 2006-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102269751B (zh) | 六味能消制剂的检测方法 | |
CN1739598A (zh) | 一种用于治疗癌症的中药注射剂及其制法和质量控制方法 | |
CN102488837B (zh) | 治疗慢性疲劳综合症的无糖颗粒剂的检测方法 | |
CN1785293A (zh) | 心脉通口服制剂的质量控制方法 | |
CN101029889A (zh) | 一种治疗中老年眼部疾病中药制剂的质量检测方法 | |
CN1895438B (zh) | 一种治疗头痛的中药组合物及其制备方法 | |
CN100446805C (zh) | 一种治疗慢性泄泻的药物 | |
CN1323676C (zh) | 治疗脾胃虚弱的中药胶囊剂的制备方法及其质量控制方法 | |
CN1785294A (zh) | 治疗高血压症的杜仲降压制剂的质量控制方法 | |
CN100344321C (zh) | 一种药物组合物及其制备方法、质量控制方法 | |
WO2009155755A1 (zh) | 巴戟天寡糖的含量测定方法 | |
CN1824245A (zh) | 骨筋丸制剂的质量控制方法 | |
CN1879850A (zh) | 仙蟾胶囊及其制备方法、质量控制方法 | |
CN1785347A (zh) | 一种小儿高热不退的中药制剂质量控制方法 | |
CN101028348A (zh) | 一种中药胶囊及其制备方法和质量控制方法 | |
CN101336986A (zh) | 一种药物组合物及其制备方法和质量检测方法 | |
CN115956630A (zh) | 一种复方厚朴提取物及其制备方法、质量控制方法 | |
CN1857445A (zh) | 一种得生制剂的质量控制方法 | |
CN107582639A (zh) | 一种醋延胡索配方颗粒及其制备方法 | |
CN1895396A (zh) | 一种滋阴润肠导滞通便的中药制剂及其制备方法 | |
CN1857588A (zh) | 一种仙灵骨葆制剂的质量控制方法 | |
CN1857424A (zh) | 一种中药复方制剂及其制备方法、质量控制方法 | |
CN100344312C (zh) | 一种治疗儿童多动症的颗粒剂的制备方法和质量控制方法 | |
CN1559524A (zh) | 一种治疗小儿肺热咳喘的药物及其制备方法 | |
CN1839982A (zh) | 前列安通胶囊及其制备方法、质量控制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LUO GUANDI Free format text: FORMER OWNER: WU SHAOHUI Effective date: 20140723 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 515556 JIEYANG, GUANGDONG PROVINCE TO: 510507 GUANGZHOU, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140723 Address after: 510507 room 12, building 91, 601 Zhuang Road, Tianhe District, Guangdong, Guangzhou, Dongguan Patentee after: Luo Guandi Address before: Guangdong County of Jiedong province Baoshan 515556 cloud Patentee before: Wu Shaohui |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070704 Termination date: 20150706 |
|
EXPY | Termination of patent right or utility model |